Domicile
Reels
Groupes
Pages
Plus
Groupes Pages Evènements Blogs Financement
Se connecter S’enregistrer
Mode nuit
Targeted Therapy and the NSCLC Market: Matching Drugs to Mutations
Targeted therapies have transformed outcomes for subsets of NSCLC patients — and they are a major growth driver within the non-small cell lung cancer market. By matching drugs to specific genetic alterations, targeted therapy offers higher response rates and better tolerability than traditional chemotherapy for patients whose tumours carry actionable mutations. Key targets include EGFR,...
0 Commentaires ·0 Parts ·23 Vue ·0 Aperçu
Connectez-vous pour aimer, partager et commenter!